GBAF Logo
Global Banking & Finance Awards® 2026 Nominations open, free to enter Nominate now →
O

Oculis Holding OCS · USD

Health Care · US listing · 🇺🇸 United States

Compare

7.76

+3.60%

Close of 9 Nov 2026, in USD

Search any instrument

Reference data, closing prices and charts across 45,000 companies, plus crypto, commodities and currencies.

At a glance

Figures in CHF, from our data supplier.

FY2025

Revenue

—

FY2020FY2025

Net income

−CHF 116.3m

FY2020FY2025

Free cash flow

−CHF 76.9m

FY2020FY2025

Shareholders' equity

CHF 241.5m

FY2020FY2025

Income statement

Fiscal years

FY2025FY2024FY2023FY2022FY2021FY2020
Revenue—CHF 844,008CHF 1.1mCHF 1.1mCHF 1.2mCHF 1.2m
Research and developmentCHF 67.1mCHF 64.1mCHF 36.0mCHF 27.3mCHF 11.8mCHF 11.5m
Operating income−CHF 97.4m−CHF 90.1m−CHF 99.3m−CHF 39.8m−CHF 16.5m−CHF 15.2m
Net income−CHF 116.3m−CHF 105.5m−CHF 109.3m−CHF 47.6m−CHF 22.8m−CHF 18.3m
Diluted earnings per share-2.08-2.52-2.97-1.45-0.70-0.56

Balance sheet

At each fiscal year end

FY2025FY2024FY2023FY2022FY2021FY2020
Total assetsCHF 290.6mCHF 148.1mCHF 140.7mCHF 45.6mCHF 71.4mCHF 20.2m
Cash and short-term investmentsCHF 262.4mCHF 121.4mCHF 112.8mCHF 24.3mCHF 56.9mCHF 6.1m
Total liabilitiesCHF 49.1mCHF 57.8mCHF 25.4mCHF 166.2mCHF 146.4mCHF 73.9m
DebtCHF 618,327CHF 1.2mCHF 605,000CHF 123.1mCHF 114.3mCHF 54.8m
Shareholders' equityCHF 241.5mCHF 90.3mCHF 115.3m−CHF 120.6m−CHF 75.0m−CHF 53.7m
Shares outstanding56m42m37m33m33m33m

Cash flow

Fiscal years

FY2025FY2024FY2023FY2022FY2021FY2020
Cash from operations−CHF 76.6m−CHF 58.4m−CHF 66.2m−CHF 30.8m−CHF 17.0m−CHF 14.8m
Capital spending−CHF 353,684−CHF 282,977−CHF 59,056−CHF 4.4m−CHF 34,449−CHF 23,376
Free cash flow−CHF 76.9m−CHF 58.7m−CHF 66.3m−CHF 35.2m−CHF 17.0m−CHF 14.8m

Latest quarters

By quarter end

Jun 2026Mar 2026Dec 2025Sept 2025Jun 2025Mar 2025Dec 2024Sept 2024
Revenue———CHF 298,971CHF 321,117———
Operating income−CHF 29.0m−CHF 27.6m−CHF 25.7m−CHF 25.0m−CHF 25.6m−CHF 24.6m−CHF 21.2m−CHF 22.3m
Net income−CHF 12.3m−CHF 36.3m−CHF 28.7m−CHF 20.7m−CHF 31.2m−CHF 40.9m−CHF 35.3m−CHF 24.8m
Diluted earnings per share-0.20-0.59-0.51-0.37-0.56-0.73-0.84-0.59
Cash from operations−CHF 24.0m−CHF 19.0m−CHF 20.0m−CHF 16.0m−CHF 21.0m−CHF 23.0m−CHF 12.0m−CHF 12.0m
Capital spending—————−CHF 1.0m——
Free cash flow—————−CHF 24.0m——
Total assetsCHF 308.0mCHF 299.3mCHF 290.6mCHF 206.5mCHF 223.5mCHF 251.2mCHF 148.1mCHF 154.5m
Cash and short-term investmentsCHF 280.9mCHF 272.4mCHF 262.4mCHF 57.1mCHF 197.2mCHF 223.8mCHF 121.4mCHF 129.8m
DebtCHF 1.8mCHF 510,288CHF 618,327CHF 517,970CHF 381,403CHF 374,021CHF 387,555CHF 386,325
Shareholders' equityCHF 269.9mCHF 241.2mCHF 241.5mCHF 160.7mCHF 176.1mCHF 200.1mCHF 90.3mCHF 117.2m

Financial ratios

Data as of 4 Nov 2026

FY2025FY2024FY2023FY2022FY2021FY2020
Operating margin—-12527.3%-9895.8%-3530.8%-1396.3%-1241.2%
Net margin—-12503.9%-10056.9%-4243.2%-1932.5%-1497.8%
Return on equity-48.1%-116.9%-94.7%39.5%30.4%34.1%
Return on assets-40.0%-71.3%-77.7%-104.4%-32.0%-90.8%
Free cash flow yield-14.5%-14.8%-19.2%-8.6%-5.5%—
Revenue growth—-22.3%-3.2%-5.0%-3.3%—
Earnings growth10.2%-3.4%129.5%108.6%24.7%—
Current ratio5.96x2.37x5.29x1.97x11.81x1.42x
Debt to equity0.00x0.00x0.00x-1.25x-1.87x-1.24x
Equity ratio83.1%61.0%82.0%-264.4%-105.0%-266.5%
Interest coverage-118.02x-134.49x-59.71x-5.00x-2.62x-4.69x
R&D as a share of sales—7592.3%3312.2%2436.8%996.7%940.3%
Buybacks as a share of market value-33.9%-13.7%-12.3%0.0%——

Growth per year

Compound annual rate

3 years5 years10 years
Operating income34.8%45.1%—
Net income34.7%44.7%—

Valuation history

At each fiscal year end

FY2025
Price to earnings-9.6

Market value over time

28 May 2021 to 3 Nov 2026, in CHF

CHF 29.1mCHF 467.5m

Share price return

Finished calendar years

2025
Return15%

Sources and methodology

Data on this tab
Our data supplier
Chart on the Overview
TradingView

Nothing here is investment advice. Prices can be delayed or wrong, so check with the exchange before relying on them. Data for this page. How we cover markets.